Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Available from: http://www.eurosurveillance.org / ViewArticle.aspx?ArticleId=21169


In this issue


Home Eurosurveillance Edition  2013: Volume 18/ Issue 38 Article 5
Back to Table of Contents
Previous Download (pdf)
Next

Eurosurveillance, Volume 18, Issue 38, 19 September 2013
News
CDC publishes report on antibiotic resistance threats in the United States for the first time
  1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Citation style for this article: Eurosurveillance editorial team. CDC publishes report on antibiotic resistance threats in the United States for the first time. Euro Surveill. 2013;18(38):pii=20588. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20588

To raise awareness of the burden and threats posed by antibiotic resistance and to encourage immediate action, the United States (US) Centers for Disease Control and Prevention (CDC) released its first ever report on antibiotic resistance threats in the US – Antibiotic resistance threats in the United States, 2013 [1].

Antimicrobial resistance represents a serious threat to public health and patient safety and is a worldwide problem. This report is aimed at a wide audience including health professionals and policy makers, as well as the general public.

Section 1 of the report describes the context and provides an overview of antimicrobial resistance in the US. Section 2 describes the four core actions to fight antibiotic resistance: preventing infections and the spread of resistance, tracking resistance patterns, antibiotic stewardship (improving prescribing and improving use) and developing new antibiotics and diagnostic tests. Section 3 provides a summary for each resistant bacterium considered as a threat for the US and further describes antibiotic resistance, the burden of disease and actions to fight the spread of resistance.

The European Centre for Disease Prevention and Control (ECDC) published a comment on the ECDC website with background information on the situation in Europe and links to relevant publications [2].


References

  1. Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. Atlanta: CDC; 2013. Available from: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
  2. European Centre for Disease Prevention and Control (ECDC). US CDC report on antibiotic resistance threats in the United States, 2013. Stockholm: ECDC. 18 Sep 2013. Available from: http://www.ecdc.europa.eu/en/activities/sciadvice/_layouts/forms/Review_DispForm.aspx?List=a3216f4c-f040-4f51-9f77-a96046dbfd72&ID=752&RootFolder=%2Fen%2Factivities%2Fsciadvice%2FLists%2FECDC%20Reviews&Web=0be238ef-4498-4962-8826-2e082a1f1639


Back to Table of Contents
Previous Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.